Personalized strategies in population screening for prostate cancer

This review discusses evidence for population‐based screening with contemporary screening tools. In Europe, prostate‐specific antigen (PSA)‐based screening led to a relative reduction of prostate cancer (PCa) mortality, but also to a substantial amount of overdiagnosis and unnecessarily biopsies. Ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Remmers, Sebastiaan, Roobol, Monique J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Invited Review series on Personalized Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586980/
https://www.ncbi.nlm.nih.gov/pubmed/32394421
http://dx.doi.org/10.1002/ijc.33045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586980/
https://www.ncbi.nlm.nih.gov/pubmed/32394421
http://dx.doi.org/10.1002/ijc.33045

Ejemplares similares